I can't argue with that sentiment as we are all sharing the same reality but i don't think management are to blame. They have made excellent progress, with even more exciting developments around the corner, should the trial results be positive as we expect. For some reason the sp just can't gain traction. But at least we weren't all hype and the sp crashed 40-70% like some other companies have. We are still in a very healthy position. Personally i would have thought we would be $2 by now and any jnj news taking us to $5.
Stem Cell Therapy advancements, page-251
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $139.0M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 66.5¢ | 64.5¢ | $276.6K | 421.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 25500 | 65.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.0¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |